Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays

Screening for specific genetic aberrations by fluorescence and chromogenic in situ hybridization (fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH)) can reveal associations with tumor types or subtypes, cellular morphology and clinical behavior. FISH and CISH methodologies are based on the specific annealing (hybridization) of labeled genomic sequences (probes) to complementary nucleic acids within fixed cells to allow their detection, quantification and spatial localization. Formalin-fixed paraffin embedded (FFPE) material is the most widely available source of tumor samples. Increasingly, tissue microarrays (TMAs) consisting of multiple cores of FFPE material are being used to enable simultaneous analyses of many archival samples. Here we describe robust protocols for the FISH and CISH analyses of genetic aberrations in FFPE tissue, including TMAs. Protocols include probe preparation, hybridization and detection. Steps are described to reduce background fluorescence and strip probes for repeat FISH analyses to maximize the use of tissue resources. The basic protocol takes 2–3 d to complete.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  Bramwell Nh,et al.  The effects of fixative type and fixation time on the quantity and quality of extractable DNA for hybridization studies on lymphoid tissue , 1988 .

[3]  N. Bramwell,et al.  The effects of fixative type and fixation time on the quantity and quality of extractable DNA for hybridization studies on lymphoid tissue. , 1988, Experimental hematology.

[4]  J. Rossi,et al.  Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  D. Pinkel,et al.  Molecular cytogenetics: diagnosis and prognostic assessment. , 1992, Current opinion in biotechnology.

[6]  C. Cooper,et al.  Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. , 1996, The American journal of pathology.

[7]  K. Rodenacker,et al.  Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-micron and 15-micron paraffin-embedded tissue sections from prostatic carcinoma. , 1997, Histochemistry and cell biology.

[8]  K. Rodenacker,et al.  Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-μm and 15-μm paraffin-embedded tissue sections from prostatic carcinoma , 1997, Histochemistry and Cell Biology.

[9]  C. Fisher,et al.  Chromosome translocations in sarcomas and the analysis of paraffin‐embedded material , 1998, The Journal of pathology.

[10]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[11]  M. Ladanyi,et al.  Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[12]  Yong-jie Lu,et al.  Synovial sarcoma specific translocation associated with both epithelial and spindle cell components , 1999, International journal of cancer.

[13]  D. Smedley,et al.  Dual colour fluorescence in situ hybridization to paraffin‐embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma , 1999, The Journal of pathology.

[14]  H. Moch,et al.  Tissue microarrays for gene amplification surveys in many different tumor types. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  D. Smedley,et al.  Characterization of chromosome 1 abnormalities in malignant melanomas , 2000, Genes, chromosomes & cancer.

[16]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[17]  D. Larsimont,et al.  Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. , 2000, The American journal of pathology.

[18]  W. Baschong,et al.  Control of Autofluorescence of Archival Formaldehyde-fixed, Paraffin-embedded Tissue in Confocal Laser Scanning Microscopy (CLSM) , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[20]  S. Jewell,et al.  Copyright © American Society for Investigative Pathology Review Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids , 2022 .

[21]  V. Zsikla,et al.  Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR , 2004, Journal of Clinical Pathology.

[22]  Yong-jie Lu,et al.  Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  W. Gerald,et al.  Gene expression profiling in single cells within tissue , 2005, Nature Methods.

[24]  D. Ruiter,et al.  Multiplex Ligation-Dependent Probe Amplification for the Detection of Chromosomal Gains and Losses in Formalin-Fixed Tissue , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[25]  J. Shipley Putting the colours into chromogenic in situ hybridization (CISH) , 2006, The Journal of pathology.

[26]  D. Huntsman,et al.  Fluorescent in situ hybridization on tissue microarrays: challenges and solutions , 2007, Journal of Molecular Histology.

[27]  A. Ashworth,et al.  Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization , 2006, Laboratory Investigation.

[28]  J. Isola,et al.  Dual‐colour chromogenic in situ hybridization for testing of HER‐2 oncogene amplification in archival breast tumours , 2006, The Journal of pathology.

[29]  J. Shipley,et al.  Clinical relevance of molecular genetics to paediatric sarcomas , 2007, Journal of Clinical Pathology.

[30]  J. Squire,et al.  Application and interpretation of FISH in biomarker studies. , 2007, Cancer letters.

[31]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[32]  Rachael Natrajan,et al.  Chromogenic and fluorescent in situ hybridization in breast cancer. , 2007, Human pathology.

[33]  J Cuzick,et al.  Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer , 2008, Oncogene.

[34]  Yi Sun,et al.  Challenges and Solutions for 10Gbps PON , 2008 .

[35]  J. Cuzick,et al.  Complex patterns of ETS gene alteration arise during cancer development in the human prostate , 2008, Oncogene.